SE8702698L - POLYPEPTIME, USEFUL FOR THE PREPARATION OF ANTIMALARIA VACCINES AND DIAGNOSTIC TEST FOR THE DISEASE OF MALARIA DISEASES - Google Patents

POLYPEPTIME, USEFUL FOR THE PREPARATION OF ANTIMALARIA VACCINES AND DIAGNOSTIC TEST FOR THE DISEASE OF MALARIA DISEASES

Info

Publication number
SE8702698L
SE8702698L SE8702698A SE8702698A SE8702698L SE 8702698 L SE8702698 L SE 8702698L SE 8702698 A SE8702698 A SE 8702698A SE 8702698 A SE8702698 A SE 8702698A SE 8702698 L SE8702698 L SE 8702698L
Authority
SE
Sweden
Prior art keywords
polypeptime
disease
useful
preparation
diagnostic test
Prior art date
Application number
SE8702698A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE8702698D0 (en
SE468393B (en
Inventor
A Bernardi
F Bonelli
A Pessi
A S Verdini
Original Assignee
Eniricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eniricerche Spa filed Critical Eniricerche Spa
Publication of SE8702698D0 publication Critical patent/SE8702698D0/en
Publication of SE8702698L publication Critical patent/SE8702698L/en
Publication of SE468393B publication Critical patent/SE468393B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The peptides are based the CS protein of Plasmodium falciparum sporozoites and comprise the region I of the protein and a plurality of repetitive tetrapeptide units of CS protein linked to each other by a peptide bond between the tail proline of region I and the head asparagine of the first tetrapeptide as shown in the general formula:- <IMAGE>
SE8702698A 1986-07-16 1987-06-30 POLYPEPTIME, USEFUL FOR PREPARATION OF ANTIMALARIA VACCINES AND DIAGNOSTIC TEST FOR DETECTION OF MALARIARY DISEASES SE468393B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21144/86A IT1196501B (en) 1986-07-16 1986-07-16 POLYPEPTIDE USEFUL FOR THE PREPARATION OF MALARIA VACCINES AND DIAGNOSTIC KITS FOR THE DETERMINATION OF MALARIC DISEASES

Publications (3)

Publication Number Publication Date
SE8702698D0 SE8702698D0 (en) 1987-06-30
SE8702698L true SE8702698L (en) 1988-01-17
SE468393B SE468393B (en) 1993-01-11

Family

ID=11177390

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8702698A SE468393B (en) 1986-07-16 1987-06-30 POLYPEPTIME, USEFUL FOR PREPARATION OF ANTIMALARIA VACCINES AND DIAGNOSTIC TEST FOR DETECTION OF MALARIARY DISEASES

Country Status (13)

Country Link
AT (1) ATA179087A (en)
BE (1) BE1000729A4 (en)
CH (1) CH673461A5 (en)
DE (1) DE3723583A1 (en)
ES (1) ES2008151A6 (en)
FR (1) FR2601590B1 (en)
GB (1) GB2193215B (en)
GR (1) GR871021B (en)
IT (1) IT1196501B (en)
NL (1) NL8701686A (en)
OA (1) OA08626A (en)
SE (1) SE468393B (en)
ZA (1) ZA874778B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2006700A1 (en) * 1989-01-17 1990-07-17 Antonello Pessi Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
CA2031468A1 (en) * 1989-12-08 1991-06-09 Mitchell S. Gross Malaria vaccine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
ES8800273A1 (en) * 1985-03-28 1987-11-01 Univ New York Immunogenic antigen-carrier protein conjugate for use in a vaccine against malaria.
IT1187710B (en) * 1985-07-25 1987-12-23 Eniricerche Spa USEFUL PEPTIDAL COMPOSITION FOR THE PREPARATION OF MALARIA VACCINES AND DIAGNOSTIC KITS FOR THE DETERMINATION OF MALARIC DISEASES

Also Published As

Publication number Publication date
NL8701686A (en) 1988-02-16
ES2008151A6 (en) 1989-07-16
ZA874778B (en) 1988-01-13
GB2193215A (en) 1988-02-03
SE8702698D0 (en) 1987-06-30
BE1000729A4 (en) 1989-03-21
GR871021B (en) 1987-11-13
GB2193215B (en) 1990-03-07
ATA179087A (en) 1996-07-15
IT8621144A0 (en) 1986-07-16
CH673461A5 (en) 1990-03-15
FR2601590A1 (en) 1988-01-22
DE3723583A1 (en) 1988-01-28
OA08626A (en) 1988-11-30
IT1196501B (en) 1988-11-16
SE468393B (en) 1993-01-11
FR2601590B1 (en) 1990-05-18
DE3723583C2 (en) 1991-06-13
GB8715737D0 (en) 1987-08-12

Similar Documents

Publication Publication Date Title
DE69428214D1 (en) TRANSFORMING GROWTH FACTOR ALPHA H1
ATE456658T1 (en) RECOMBINANT PROTEIN CONTAINING A C-TERMINAL FRAGMENT OF MSP-1 FROM PLASMODIUM
PT82975A (en) Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein and of vaccine against the malaria
CA2462946A1 (en) Recombinant p. falciparum merozoite protein-142 vaccine
IL75788A (en) Peptide comprising a repeated sequence of four amino acids,which sequence occurs in plasmodium falciparum circumsporozoite protein
ES8800273A1 (en) Immunogenic antigen-carrier protein conjugate for use in a vaccine against malaria.
DE3685917D1 (en) PEPTIDE COMPOSITION FOR THE PRODUCTION OF MALARIA VACCINE, AND FOR THE PREPARATION OF DIAGNOSTIC ITEMS FOR THE DETECTION OF MALARIA-LIKE DISEASES.
SE8702698D0 (en) POLYPEPTIME, USEFUL FOR THE PREPARATION OF ANTIMALARIA VACCINES AND DIAGNOSTIC TEST FOR THE DISEASE OF MALARIA DISEASES
FI882891A (en) Method for producing an angiogenic factor
PT86639A (en) EXPRESSION OF P. FALCIPARUM&#39;S SPOROZOITE PHASE PROTEIN BY YEAST
BR9604989A (en) Modified polypeptides for improved immunogenicity and production process
ES2006730A6 (en) ASEXUAL BLOOD STAGE ANTIGENS OF -i(PLASMODIUM FALCIPARUM).
DE69230106D1 (en) PEPTIDE-ANTIGENE COMPOSED OF MULTI-DETERMINANTS THAT STIMULATE THE T-HELPER&#39;S LYMPHOCYTE RESPONSE TO HIV IN A WIDE RANGE OF AFFECTED PEOPLE
IT1217314B (en) SYNTHETIC NONAPEPTIDE WITH ADJUVANT ACTIVITY CAPABLE OF ENHANCING THE ANTI-CORPORAL RESPONSE IN VIVO
ATE110741T1 (en) SYNTHETIC PEPTIDES SHOWING IMMUNOLOGICAL ACTIVITY USABLE TO PREPARE A VACCINATION AGAINST MALARIA.
ES2037795T3 (en) PROCEDURE FOR THE PREPARATION OF ANTIGEN HRPII FROM PLASMODIUM FALCIPARUM SGE2.
SE8803062D0 (en) SEQUENTIAL POLYPEPTIDES ENDOWED WITH IMMUNOLOGICAL ACTIVITY
IL94063A0 (en) Plasmodium circumsporozoite protein analogs lacking repeat sequences and their expression by recombinant methods
SE9000793D0 (en) SDK PEPTIDES, PROCEDURES FOR PREPARING THEM AND THERAPEUTIC COMPOSITIONS CONTAINING THEM
DE68905860D1 (en) SYNTHETIC, IMMUNOLOGICALLY ACTIVE PEPTIDES, WHICH ARE FOR THE PREPARATION OF VACCINES AGAINST MALARIA SERVES.
IL92774A (en) Vaccines having as active ingredient a peptide comprising a repetitive amino acid sequence of the immunodominant epitope of plasmodium circumsporozoite protein
IT1224501B (en) PROCEDURE FOR PREPARING HIGH PURITY SILIBINE TO OBTAIN ANTIHEPATOTOXIC ACTION PREPARATIONS

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8702698-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8702698-5

Format of ref document f/p: F